Ford to Donate $20 to Susan G. Komen for the Cure® for Every Customer Test Drive
Ford Motor Company is committed to the fight against breast cancer, and is a proud supporter of breast cancer research and critical breast cancer services. Over the years Ford has dedicated more than $100 million to the Susan G. Komen for the Cure fight against breast cancer.
To further show their support, Ford will donate $20, up to $1 million, to the Susan G. Komen for the Cure® in the name of each prospective customer that test drives a Ford, Lincoln or Mercury vehicle through June 1. This charitable initiative will run alongside the Ford Advantage Plan, designed to boost consumer confidence by offering valued Ford customers a guaranteed 12 months of vehicle payments on any new Ford, Lincoln or Mercury vehicle up to $700 a month, if the customer loses his/her job.
Customers interested in a test drive can join in and participate by logging on to www.fordcares.com and getting a registration form and number to provide to their dealer. Customers participating in any upcoming Komen Race for the Cure event through June 1st will receive a registration form and can also follow the same steps to have a $20 donation made on their behalf as well.
Twitter users can follow this story @Ford. Please help by getting the word out by sending a tweet. Here's a sample: For test drives until 6/1, Ford donates $20 to Komen for the Cure. RT and @ at least ONE woman you love! http://is.gd/unhl
Quotes:
“Our goal with the Ford Advantage Plan is to rebuild consumer confidence and assist local charitable organizations that also are struggling in this economy.” - Ken Czubay, vice president of Sales and Marketing, Ford Motor Company
“This program will go a long way in helping Komen directly serve women and men in hundreds of communities across the country with education, screening and treatment programs that address breast cancer issues close to home.” - Hala Moddelmog, President and CEO, Susan G. Komen for the Cure.
Tags: Ford, Ford Advantage Plan, Ford Motor Company, Susan G. Komen for the Cure
